DANIEL GLINOER, M.D., Ph.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The recent review by Graham and Burman (1) proposes greater use of radioiodine as primary treatment in Graves disease. Similar views have recently been proposed by Hennemann and associates (2). The proposal made by these authors to extend the indications for radioiodine treatment is, however, contradicted to a large extent by the facts.
In 1986, members of the European Thyroid Association were invited to participate in a survey on the management of hyperthyroidism due to Graves disease (3). The aim of the survey was to assess the use of diagnostic procedures and therapeutic practices in European centers
GLINOER D. Radioiodine for Graves Disease. Ann Intern Med. ;106:637. doi: 10.7326/0003-4819-106-4-637_1
Download citation file:
Published: Ann Intern Med. 1987;106(4):637.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use